Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Markia A Smith"'
Autor:
Maya L Gosztyla, Lydia Kwong, Naomi A Murray, Claire E Williams, Nicholas Behnke, Porsia Curry, Kevin D Corbett, Karen N DSouza, Julia Gala de Pablo, Joanina Gicobi, Monica Javidnia, Navina Lotay, Sidney Madison Prescott, James P Quinn, Zeena M G Rivera, Markia A Smith, Karen T Y Tang, Aarya Venkat, Megan A Yamoah
Publikováno v:
PLoS Computational Biology, Vol 17, Iss 7, p e1009141 (2021)
Externí odkaz:
https://doaj.org/article/d455ce46fb064fe5967c66ace9da88af
Autor:
Melissa A. Troester, Katherine A. Hoadley, Cyrus Vaziri, Charles M. Perou, Gaorav P. Gupta, Michael I. Love, Erin L. Kirk, Alina M. Hamilton, Xiaohua Gao, Alex Lockhart, Markia A. Smith, Linnea T. Olsson, Sarah C. Van Alsten, Andrea Walens
Background:Aberrant expression of DNA repair pathways such as homologous recombination (HR) can lead to DNA repair imbalance, genomic instability, and altered chemotherapy response. DNA repair imbalance may predict prognosis, but variation in DNA rep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26082be2ddd4e39d8e04cca6b3b9f150
https://doi.org/10.1158/1055-9965.c.6660312.v1
https://doi.org/10.1158/1055-9965.c.6660312.v1
Autor:
Melissa A. Troester, Katherine A. Hoadley, Cyrus Vaziri, Charles M. Perou, Gaorav P. Gupta, Michael I. Love, Erin L. Kirk, Alina M. Hamilton, Xiaohua Gao, Alex Lockhart, Markia A. Smith, Linnea T. Olsson, Sarah C. Van Alsten, Andrea Walens
Supplementary Figure from RNA-Based Classification of Homologous Recombination Deficiency in Racially Diverse Patients with Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04cd3e65fc8112cd41e42cf4195fbcb1
https://doi.org/10.1158/1055-9965.23099349.v1
https://doi.org/10.1158/1055-9965.23099349.v1
Autor:
Ji-Eun Park, Markia A. Smith, Sarah C. Van Alsten, Andrea Walens, Di Wu, Katherine A. Hoadley, Melissa A. Troester, Michael I. Love
Publikováno v:
bioRxiv
Somatic mutational signatures elucidate molecular vulnerabilities to therapy and therefore detecting signatures and classifying tumors with respect to signatures has clinical value. However, identifying the etiology of the mutational signatures remai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d1e6445c284d9bc9e2c3fee8c72cd98
https://doi.org/10.1101/2023.02.09.527740
https://doi.org/10.1101/2023.02.09.527740
Autor:
Markia A. Smith, Sarah C. Van Alsten, Andrea Walens, Jeffrey S. Damrauer, Ugwuji N. Maduekwe, Russell R. Broaddus, Michael I. Love, Melissa A. Troester, Katherine A. Hoadley
Publikováno v:
Cancers; Volume 14; Issue 17; Pages: 4282
DNA repair pathways have been associated with variability in hepatocellular carcinoma (HCC) clinical outcomes, but the mechanism through which DNA repair varies as a function of liver regeneration and other HCC characteristics is poorly understood. W
Autor:
Susana, Garcia-Recio, Toshinori, Hinoue, Gregory L, Wheeler, Benjamin J, Kelly, Ana C, Garrido-Castro, Tomas, Pascual, Aguirre A, De Cubas, Youli, Xia, Brooke M, Felsheim, Marni B, McClure, Andrei, Rajkovic, Ezgi, Karaesmen, Markia A, Smith, Cheng, Fan, Paula I Gonzalez, Ericsson, Melinda E, Sanders, Chad J, Creighton, Jay, Bowen, Kristen, Leraas, Robyn T, Burns, Sara, Coppens, Amy, Wheless, Salma, Rezk, Amy L, Garrett, Joel S, Parker, Kelly K, Foy, Hui, Shen, Ben H, Park, Ian, Krop, Carey, Anders, Julie, Gastier-Foster, Mothaffar F, Rimawi, Rita, Nanda, Nancy U, Lin, Claudine, Isaacs, P Kelly, Marcom, Anna Maria, Storniolo, Fergus J, Couch, Uma, Chandran, Michael, Davis, Jonathan, Silverstein, Alexander, Ropelewski, Minetta C, Liu, Susan G, Hilsenbeck, Larry, Norton, Andrea L, Richardson, W Fraser, Symmans, Antonio C, Wolff, Nancy E, Davidson, Lisa A, Carey, Adrian V, Lee, Justin M, Balko, Katherine A, Hoadley, Peter W, Laird, Elaine R, Mardis, Tari A, King
Publikováno v:
Nature cancer.
The AURORA US Metastasis Project was established with the goal to identify molecular features associated with metastasis. We assayed 55 females with metastatic breast cancer (51 primary cancers and 102 metastases) by RNA sequencing, tumor/germline DN
Autor:
G. Iyer, Hikmat Al-Ahmadie, Erin L. Kirk, David B. Solit, Eugene J. Pietzak, William Y. Kim, Sara E. Wobker, Markia A. Smith, Kyle Roell, Matthew E. Nielsen, Bernard H. Bochner, Melissa A. Troester, Helena Furberg, Guido Dalbagni, Jeffrey S. Damrauer, Andrew F. Olshan, Katherine A. Hoadley, Halei C. Benefield, Matthew I. Milowsky, Xuezheng Sun
Publikováno v:
Clin Cancer Res
Purpose: Improved risk stratification and predictive biomarkers of treatment response are needed for non–muscle-invasive bladder cancer (NMIBC). Here we assessed the clinical utility of targeted RNA and DNA molecular profiling in NMIBC. Experimenta
Autor:
Andrea Walens, Sarah C. Van Alsten, Linnea T. Olsson, Markia A. Smith, Alex Lockhart, Xiaohua Gao, Alina M. Hamilton, Erin L. Kirk, Michael I. Love, Gaorav P. Gupta, Charles M. Perou, Cyrus Vaziri, Katherine A. Hoadley, Melissa A. Troester
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 31(12)
Background: Aberrant expression of DNA repair pathways such as homologous recombination (HR) can lead to DNA repair imbalance, genomic instability, and altered chemotherapy response. DNA repair imbalance may predict prognosis, but variation in DNA re
Autor:
Markia A. Smith, Jeffrey S. Damrauer, Lisle E. Mose, Sara R. Selitsky, Aatish Thennavan, Vonn Walter, Katherine A. Hoadley
Publikováno v:
Communications Biology, Vol 4, Iss 1, Pp 1-13 (2021)
Communications Biology
Communications Biology
Primary liver cancer, consisting of both cholangiocarcinoma (CCA) and hepatocellular carcinoma (HCC), is the second leading cause of cancer deaths worldwide. Our goal is to genomically characterize rare HCC subclasses to provide insight into disease
Autor:
Matthew E. Nielsen, Hikmat Al-Ahmadie, David B. Solit, William Y. Kim, Kyle Roell, Guido Dalbagni, Melissa A. Troester, Sara E. Wobker, Xuezheng Sun, Gopa Iyer, Matthew I. Milowsky, Helena Furberg, Jeffrey S. Damrauer, Andrew F. Olshan, Bernard H. Bochner, Katherine A. Hoadley, Markia A. Smith, Erin L. Kirk, Halei C. Benefield, Eugene J. Pietzak
Publikováno v:
Journal of Urology. 206
INTRODUCTION AND OBJECTIVE:Improved risk stratification and predictive biomarkers of treatment response are needed for non-muscle-invasive bladder cancer (NMIBC). Here we assessed the clinical util...